ID

39729

Beschreibung

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01685203

Link

https://clinicaltrials.gov/show/NCT01685203

Stichworte

Versionen (1)
  1. 13.02.20 13.02.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

13. Februar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis C, Chronic NCT01685203

Englisch

Eligibility Hepatitis C, Chronic NCT01685203

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
females must be practicing specific forms of birth control on study treatment, or be postmenopausal for more than 2 years or surgically sterile
Beschreibung

Gender Contraceptive methods | Postmenopausal state Duration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0449238
subjects must meet one of the following:
Beschreibung

Criteria Quantity Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
treatment-naive: subject has never received antiviral treatment for hepatitis c infection or
Beschreibung

Therapy naive | Antiviral Therapy Absent Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0280274
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0019196
treatment experienced (prior null responders, partial responders or relapsers to pegifn/rbv);
Beschreibung

Therapeutic procedure Experience | Non-responder PEGINTERFERON/RIBAVIRIN | Partial responder PEGINTERFERON/RIBAVIRIN | Relapse PEGINTERFERON/RIBAVIRIN

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0596545
UMLS CUI [2,1]
C0919875
UMLS CUI [2,2]
C1875630
UMLS CUI [3,1]
C4285679
UMLS CUI [3,2]
C1875630
UMLS CUI [4,1]
C0035020
UMLS CUI [4,2]
C1875630
body mass index (bmi) is ≥ 18 to < 38 kg/m^2.
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
chronic hcv genotype 1b infection/with or without cirrhosis or hcv genotype 4 infection/without cirrhosis for at least 6 months prior to study screening.
Beschreibung

Chronic Hepatitis C Genotype Duration | Liver Cirrhosis | Liver Cirrhosis Absent | Hepatitis C Genotype Duration | Liver Cirrhosis Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
UMLS CUI [1,3]
C0449238
UMLS CUI [2]
C0023890
UMLS CUI [3,1]
C0023890
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0019196
UMLS CUI [4,2]
C1533728
UMLS CUI [4,3]
C0449238
UMLS CUI [5,1]
C0023890
UMLS CUI [5,2]
C0332197
subject has plasma hcv rna level > 10,000 iu/ml at screening
Beschreibung

Hepatitis C virus RNA assay Plasma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1272251
UMLS CUI [1,2]
C0032105
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of severe, life-threatening or other significant sensitivity to any drug.
Beschreibung

Drug Allergy Severe Life Threatening | Drug Allergy Significant

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C2826244
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C0750502
females who were pregnant or planned to become pregnant, or breastfeeding, or gt4-infected males whose partners were pregnant or planning to become pregnant within 7 months (or per local rbv label) after their last dose of study drug/rbv.
Beschreibung

Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Hepatitis C Genotype | Gender Partner Pregnancy | Gender Partner Planned Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0019196
UMLS CUI [4,3]
C1533728
UMLS CUI [5,1]
C0079399
UMLS CUI [5,2]
C0682323
UMLS CUI [5,3]
C0032961
UMLS CUI [6,1]
C0079399
UMLS CUI [6,2]
C0682323
UMLS CUI [6,3]
C0032992
recent history of drug or alcohol abuse that could preclude adherence to the protocol.
Beschreibung

Substance Use Disorder Excludes Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
positive test result for hepatitis b surface antigen or anti-human immunodeficiency virus (hiv) antibodies.
Beschreibung

Hepatitis B surface antigen positive | HIV antibody positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0920548
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis C, Chronic NCT01685203

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender Contraceptive methods | Postmenopausal state Duration
Item
females must be practicing specific forms of birth control on study treatment, or be postmenopausal for more than 2 years or surgically sterile
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
Criteria Quantity Fulfill
Item
subjects must meet one of the following:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Therapy naive | Antiviral Therapy Absent Hepatitis C
Item
treatment-naive: subject has never received antiviral treatment for hepatitis c infection or
boolean
C0919936 (UMLS CUI [1])
C0280274 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0019196 (UMLS CUI [2,3])
Therapeutic procedure Experience | Non-responder PEGINTERFERON/RIBAVIRIN | Partial responder PEGINTERFERON/RIBAVIRIN | Relapse PEGINTERFERON/RIBAVIRIN
Item
treatment experienced (prior null responders, partial responders or relapsers to pegifn/rbv);
boolean
C0087111 (UMLS CUI [1,1])
C0596545 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C1875630 (UMLS CUI [2,2])
C4285679 (UMLS CUI [3,1])
C1875630 (UMLS CUI [3,2])
C0035020 (UMLS CUI [4,1])
C1875630 (UMLS CUI [4,2])
Body mass index
Item
body mass index (bmi) is ≥ 18 to < 38 kg/m^2.
boolean
C1305855 (UMLS CUI [1])
Chronic Hepatitis C Genotype Duration | Liver Cirrhosis | Liver Cirrhosis Absent | Hepatitis C Genotype Duration | Liver Cirrhosis Absent
Item
chronic hcv genotype 1b infection/with or without cirrhosis or hcv genotype 4 infection/without cirrhosis for at least 6 months prior to study screening.
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0023890 (UMLS CUI [2])
C0023890 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0019196 (UMLS CUI [4,1])
C1533728 (UMLS CUI [4,2])
C0449238 (UMLS CUI [4,3])
C0023890 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Hepatitis C virus RNA assay Plasma
Item
subject has plasma hcv rna level > 10,000 iu/ml at screening
boolean
C1272251 (UMLS CUI [1,1])
C0032105 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Drug Allergy Severe Life Threatening | Drug Allergy Significant
Item
history of severe, life-threatening or other significant sensitivity to any drug.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2826244 (UMLS CUI [1,3])
C0013182 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Hepatitis C Genotype | Gender Partner Pregnancy | Gender Partner Planned Pregnancy
Item
females who were pregnant or planned to become pregnant, or breastfeeding, or gt4-infected males whose partners were pregnant or planning to become pregnant within 7 months (or per local rbv label) after their last dose of study drug/rbv.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0019196 (UMLS CUI [4,2])
C1533728 (UMLS CUI [4,3])
C0079399 (UMLS CUI [5,1])
C0682323 (UMLS CUI [5,2])
C0032961 (UMLS CUI [5,3])
C0079399 (UMLS CUI [6,1])
C0682323 (UMLS CUI [6,2])
C0032992 (UMLS CUI [6,3])
Substance Use Disorder Excludes Protocol Compliance
Item
recent history of drug or alcohol abuse that could preclude adherence to the protocol.
boolean
C0038586 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Hepatitis B surface antigen positive | HIV antibody positive
Item
positive test result for hepatitis b surface antigen or anti-human immunodeficiency virus (hiv) antibodies.
boolean
C0149709 (UMLS CUI [1])
C0920548 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video